Some DBV Technologies (EPA:DBV) Shareholders Have Taken A Painful 83% Share Price Drop

DBV Technologies S.A. (EPA:DBV) shareholders will doubtless be very grateful to see the share price up 43% in the last month. But only the myopic could ignore the astounding decline over three years. The share price has sunk like a leaky ship, down 83% in that time. So it's about time shareholders saw some gains. But the more important question is whether the underlying business can justify a higher price still.

We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you don't have to lose the lesson.

Check out our latest analysis for DBV Technologies

DBV Technologies wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

In the last three years, DBV Technologies saw its revenue grow by 9.8% per year, compound. That's a fairly respectable growth rate. So it's hard to believe the share price decline of 44% per year is due to the revenue. It could be that the losses were much larger than expected. If you buy into companies that lose money then you always risk losing money yourself. Just don't lose the lesson.

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

ENXTPA:DBV Income Statement May 12th 2020
ENXTPA:DBV Income Statement May 12th 2020

If you are thinking of buying or selling DBV Technologies stock, you should check out this FREE detailed report on its balance sheet.

Advertisement

A Different Perspective

We regret to report that DBV Technologies shareholders are down 32% for the year. Unfortunately, that's worse than the broader market decline of 11%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 24% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for DBV Technologies (1 is a bit concerning!) that you should be aware of before investing here.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on FR exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

About ENXTPA:DBV

DBV Technologies

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

High growth potential with excellent balance sheet.

Advertisement

Weekly Picks

CE
Ceazar
GOAI logo
Ceazar on Eva Live ·

This small cap is building the AI workforce of the future

Fair Value:US$7.4352.0% undervalued
76 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
TR
tripledub
LULU logo
tripledub on lululemon athletica ·

Lululemon Got Boring Right About the Time It Got Cheap. That's Usually the Point

Fair Value:US$22042.4% undervalued
25 users have followed this narrative
6 users have commented on this narrative
27 users have liked this narrative
WO
woodworthfund
KHC logo
woodworthfund on Kraft Heinz ·

Kraft Heinz (KHC): Less Drama, More Ketchup

Fair Value:US$3532.7% undervalued
8 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
CA
Canderous
TAL logo
Canderous on PetroTal ·

Beyond 2026, Beyond a Double

Fair Value:CA$1.8168.5% undervalued
27 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

BI
ARCT logo
birdflustocks on Arcturus Therapeutics Holdings ·

Arcturus Therapeutics: Strategic opportunities beyond CSL

Fair Value:US$3076.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BJ
Bjergby
BTMD logo
Bjergby on biote ·

biote Corp. (BTMD) - Regulatory Tailwind Meets Operational Reset: A Mispriced Recovery

Fair Value:US$30.3993.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ES
ELRIDGE logo
Ester on Elridge Energy Holdings Berhad ·

Elridge’s Q1 Results Strengthen the Investment Case — Earnings Growth and Margin Expansion Could Support Further Share Price Upside Ahead

Fair Value:RM 1.3237.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8590.1% undervalued
114 users have followed this narrative
2 users have commented on this narrative
31 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$268.6118.3% undervalued
1195 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative
TR
tripledub
LULU logo
tripledub on lululemon athletica ·

Lululemon Got Boring Right About the Time It Got Cheap. That's Usually the Point

Fair Value:US$22042.4% undervalued
25 users have followed this narrative
6 users have commented on this narrative
27 users have liked this narrative